Cure for cancer? UK scientists are creating a vaccine that could stop disease up to 20 years early
Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 y ...
labiotech4h
U.K. biotech defies the odds, raising £3.5B in 2024
The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.
Antibiotic Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 133 Agreements Signed by the World's Leading Biopharma Companies
The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and Licensing Deals provides a comprehensive ...
pharmaphorum18h
Next stage in GSK’s Zantac defense gets underway today
A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
MarketWatch22h
GSK PLC ADR
Teva Pharmaceutical Industries Ltd. ADR-3.78% $21.4B ...
Indiatimes20h
GSK Pharma Share Price Returns
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...